Skip to main content

Table 1 Clinical characteristics in a cohort of thirteen patients with CTX

From: Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood

Demographic

 - Gender

Female: 9

Male: 4

 

 - Familial genetics

Consanguinity: 4

Affected sibs: 6

 

Age of onset [median; mean ± SD; range] (years)

 - Diarrhea

10/13, neonatal

 - School difficulties

11/13 [10; 9.9 ± 3.2; 5–15]

 - Cataract (age of surgery)

11/13 [13; 15.4 ± 13.8; 5–54]

 - Psychiatric symptoms

6/13 [15.5; 21.2 ± 11.7; 10–40]

 - Walking difficulties

11/13 [20; 21.4 ± 10.3; 12–50]

Neurological examination

 Age at examination [median; mean ± SD; range] (years)

30; 33 ± 13.8 (18–60)

  

  - Dysmetria

Yes: 7/13

  

  - Tandem

Unable: 5/13

Abnormal: 7/13

Normal: 1/13

  - LL spasticity

Yes: 6/13

  

  - UL spasticity

Yes: 0/13

  

  - LL reflexes (knee)

Increased: 6/13

Absent: 3/13

Normal: 4/13

  - LL reflexes (ankle)

Increased: 5/13

Absent: 3/13

Normal: 5/13

  - UL reflexes

Increased: 9/13

 

Normal: 4/13

  - Plantar reflexes

Upgoing: 7/13

 

Flexor/Indifferent: 6/13

  - Romberg

Positive: 3/12

 

Negative: 9/12

  - LL proprioception

Decreased: 10/11

 

Normal: 1/11

  - UL proprioception

  

Normal: 11/11

Eye movements

   

 - Pursuit

Saccadic: 8/13

 

Normal: 5/13

 - Saccades

Dysmetric: 7/13

 

Normal: 6/13

Cognitive dysfunction

13/13

  

 - Delayed cognition

10/13

  

 - Dysexecutive/Decline

12/13

  

Paroxysmal manifestations

   

 - Myoclonic dystonia

7/13

  

 - Epilepsy

1/13

  

Osteoporosis

4/13

Tendon Xanthoma

3/13

Peripheral neuropathy

10/13 - Axonal (4/10), Demyelinating (5/10), Mixed (1/10)

Brain MRI/MRS

 - Global atrophy

3/13

 - Periventricular T2 hyperintensities

10/13

 - Increased choline peak (MRS)

13/13

 - Dentate nuclei T2 hyperintensities

12/13

 - Cerebellar atrophy

7/13